SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-147291
Filing Date
2019-05-15
Accepted
2019-05-15 08:31:50
Documents
35
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d674011d10q.htm 10-Q 214470
2 EX-31.1 d674011dex311.htm EX-31.1 6759
3 EX-31.2 d674011dex312.htm EX-31.2 6765
4 EX-32.1 d674011dex321.htm EX-32.1 4960
  Complete submission text file 0001193125-19-147291.txt   1947538

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT matn-20190331.xml EX-101.INS 476342
6 XBRL TAXONOMY EXTENSION SCHEMA matn-20190331.xsd EX-101.SCH 21378
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE matn-20190331_cal.xml EX-101.CAL 13777
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE matn-20190331_def.xml EX-101.DEF 56887
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE matn-20190331_lab.xml EX-101.LAB 161200
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE matn-20190331_pre.xml EX-101.PRE 120841
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 19825218
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1